Diagram of a scabies mite (Sarcoptes scabiei) and a skin cross-section showing a mite burrowing into the epidermis
Scabies: Pathophysiology, Clinical Features, Diagnosis, and Management
Published on
August 31, 2026
| Last Reviewed on
August 31, 2026

Scabies is a highly communicable skin disease caused by infestation with a host-specific mite. Transmission requires close personal, skin-to-skin contact, though contact with used, unwashed bedding and clothing from an affected individual can also result in infection.

Clinical Concept: Scabies mites tend to burrow in areas of warmth, such as the finger webs, axillary folds, belt line, areolae, scrotum, penis, and under the breasts. Lesions typically develop and cluster within these specific anatomic sites.

1. Clinical Presentation Across Age Groups

Scabies lesions often begin as characteristic burrows, which typically progress into vesicular or papular forms with excoriation caused by scratching. Distribution and lesion appearance vary depending on patient age and duration of infestation:

  • Infants and Younger Children: Commonly develop lesions on the palms and soles. Nodular lesions are also frequently observed in this group.
  • Older Adults: Frequently present with excoriated lesions localized to the back.
  • Long-Standing Infestation: Scaling, crusting, and extensive excoriation become prominent when infestation has been present for several weeks.

2. Diagnostic Approach

Diagnosis is made clinically based on patient health history and physical examination, focusing on the characteristic lesions and their typical distribution pattern. Confirmation can be achieved through microscopic examination of skin scrapings, which allows direct identification of mites, larvae, ova, and fecal matter.

3. Treatment & Environmental Decontamination

First-line therapy focuses on targeted topical scabicides alongside thorough environmental cleaning to prevent reinfection:

Intervention TypeTreatment / ActionInstructions & Clinical Notes
First-Line TherapyPermethrin 5% (Elimite®) LotionPreferred treatment. Apply thoroughly and leave on for 8 to 14 hours before showering or bathing.
Second-Line / DiscontinuedLindane (Kwell®)Not recommended: Carries significant risks of neurotoxicity and seizures, with lower efficacy. Absolutely contraindicated in pregnant women, children, and elderly patients.
Environmental ControlHot water washing or dry heat cycleWash bedclothes and personal items in hot water or run through a dryer cycle. Alternatively, seal items in plastic storage bags for at least 1 week (mites die within 3–4 days without host contact).

4. Post-Treatment Pruritus Management

Even after effective permethrin therapy, patients often experience persistent, severe pruritus. This occurs because dead mites and residual waste material trapped within the skin trigger a prolonged inflammatory reaction until the body naturally sheds the debris over several weeks.

To alleviate post-scabietic itching, clinicians should offer:

  • Oral Antihistamines: Particularly useful at bedtime to relieve severe nocturnal itching and aid sleep.
  • Topical Corticosteroids: Low-potency to medium-potency topical steroids applied to affected areas to reduce localized inflammation.

References

1. Barry M. Scabies. Medscape.
2. Gunning K, Pippitt K, Kiraly B, et al. Pediculosis and scabies: treatment update. Am Fam Physician. 2012;86(86):535–541.
3. James WD, Berger TG, Elston DM. Andrews’ Diseases of the Skin: Clinical Dermatology. 12th ed. Philadelphia, PA: Elsevier; 2016:445–447.

Connecting You and Primary Care
© 2026 TME HEALTHCARE. All rights reserved.